Erratum: Very low-calorie diet and 6 months of weight stability in type 2 diabetes: Pathophysiological changes in responders and nonresponders (Diabetes Care (2016) 39 (808-815) DOI: 10.2337/dc15-1942);Very low-calorie diet and 6 months of weight stability in type 2 diabetes: Pathophysiological changes in responders and nonresponders

Diabetes Care

Volumn 39, Issue 5, 2016, Pages 808-815

  Steven, Sarah ^a   Hollingsworth, Kieren G ^a   Al Mrabeh, Ahmad ^a   Avery, Leah ^a   Aribisala, Benjamin ^b   Caslake, Muriel ^c   Taylor, Roy ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LAGOS STATE UNIVERSITY   (Nigeria)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; GLUCOSE BLOOD LEVEL;

ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; FAT CONTENT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH PROGRAM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESPONSE; INSULIN SENSITIVITY; LIVER; LOW CALORY DIET; MALE; MUSCLE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS; PATHOPHYSIOLOGY; REMISSION; WEIGHT REDUCTION; BLOOD; BODY WEIGHT; BODY WEIGHT MAINTENANCE; CALORIC RESTRICTION; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; DIET RESTRICTION; DIET THERAPY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PROCEDURES; TREATMENT OUTCOME;

ADULT; BLOOD GLUCOSE; BODY WEIGHT; BODY WEIGHT MAINTENANCE; CALORIC RESTRICTION; DIABETES MELLITUS, TYPE 2; DIET, REDUCING; FASTING; FEMALE; HUMANS; INSULIN; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84964724191     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc18-er06     Document Type: Erratum

References (41)

1. Dall TM, Yang W, Halder P, et al. The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes. Diabetes Care 2014;37:3172-3179
2. Hayward RA, Reaven PD, Wiitala WL, et al.; VADT Investigators. Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2015;372:2197-2206
3. Turner RC, Cull CA, Frighi V, Holman RR; UK Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). JAMA 1999;281:2005-2012
4. Delahanty LM, Grant RW, Wittenberg E, et al. Association of diabetes-related emotional distress with diabetes treatment in primary care patients with type 2 diabetes. Diabet Med 2007;24:48-54
5. Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1985;61:917-925
6. UKPDS Group. UK prospective Diabetes Study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. Metabolism 1990;39:905-912
7. Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr 2005;82(Suppl.):222S-225S
8. Gregg EW, Chen H, Wagenknecht LE, et al.; Look AHEAD Research Group. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012;308:2489-2496
9. Lingvay I, Guth E, Islam A, Livingston E. Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care 2013;36:2741-2747
10. Jackness C, Karmally W, Febres G, etal. Very low-calorie diet mimics the early beneficial effect of Roux-en-Y gastric bypass on insulin sensitivity and β-cell function in type 2 diabetic patients. Diabetes 2013;62:3027-3032
11. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 2011;54:2506-2514
12. Steven S, Taylor R. Restoring normoglycaemia by use of a very low calorie diet in longversus short-duration type 2 diabetes. Diabet Med 2015;32:1149-1155
13. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care 2009;32:2133-2135
14. Michie S, Ashford S, Sniehotta FF, Dombrowski SU, Bishop A, French DP. A refined taxonomy of behaviour change techniques to help people change their physical activity and healthy eating behaviours: the CALO-RE taxonomy. Psychol Health 2011;26:1479-1498
15. Groop LC, Bonadonna RC, Del Prato S, et al. Glucose and free fatty acid metabolism in noninsulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989;84:205-213
16. Bjorkegren J, Packard CJ, Hamsten A, et al. Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway. J Lipid Res 1996;37:76-86
17. Al-Shayji IA, Gill JM, Cooney J, Siddiqui S, Caslake MJ. Development of a novel method to determine very low density lipoprotein kinetics. J Lipid Res 2007;48:2086-2095
18. Toschi E, Camastra S, Sironi AM, et al. Effect of acute hyperglycemia on insulin secretion in humans. Diabetes 2002;51(Suppl. 1):S130-S133
19. Taylor R, Holman RR. Normal weight individuals who develop type 2 diabetes: the personal fat threshold. Clin Sci (Lond) 2015;128:405-410
20. Steven S, Hollingsworth KG, Small PK, et al. Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes. Diabetes Care 2016;39:158-165
21. Hollingsworth KG, Al-Mrabeh A, Steven S, Taylor R. Pancreatic triacylglycerol distribution in type 2 diabetes. Diabetologia 2015;58:2676-2678
22. Lee Y, Lingvay I, Szczepaniak LS, Ravazzola M, Orci L, Unger RH. Pancreatic steatosis: harbinger of type 2 diabetes in obese rodents. Int J Obes 2010;34:396-400
23. Lalloyer F, Vandewalle B, Percevault F, et al. Peroxisome proliferator-activated receptor alpha improves pancreatic adaptation to insulin resistance in obese mice and reduces lipotoxicity in human islets. Diabetes 2006;55:1605-1613
24. Tushuizen ME, Bunck MC, Pouwels PJ, et al. Pancreatic fat content and beta-cell function in men with and without type 2 diabetes. Diabetes Care 2007;30:2916-2921
25. Lee Y, Hirose H, Ohneda M, Johnson JH, McGarry JD, Unger RH. Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A 1994;91:10878-10882
26. Tang C, Ahmed K, Gille A, et al. Loss of FFA2 and FFA3 increases insulin secretion and improves glucose tolerance in type 2 diabetes. Nat Med 2015;21:173-177
27. Pinnick KE, Collins SC, Londos C, Gauguier D, Clark A, Fielding BA. Pancreatic ectopic fat is characterized by adipocyte infiltration and altered lipid composition. Obesity (Silver Spring) 2008;16:522-530
28. UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865
29. Patel A, MacMahon S, Chalmers J, et al.; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomesinpatients with type 2 diabetes. N Engl J Med 2008;358:2560-2572
30. U. K. Prospective Diabetes Study Group. U. K. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease [published correction appears in Diabetes 1996;45:1655]. Diabetes 1995;44:1249-1258
31. Zimmet P, Alberti KG, Shaw J. Global and societal implications of the diabetes epidemic. Nature 2001;414:782-787
32. Knowler WC, Bennett PH, Hamman RF, Miller M. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota. Am J Epidemiol 1978;108:497-505
33. Farrell GC, Wong VW, Chitturi S. NAFLD in Asia-as common and important as in the West. Nat Rev Gastroenterol Hepatol 2013;10:307-318
34. Himsworth HP. Diet in the aetiology of human diabetes. Proc RSoc Med 1949;42:323-326
35. Franco M, Bilal U, Ordunez P, et al. Population-wide weight loss and regain in relation to diabetes burden and cardiovascular mortality in Cuba 1980-2010: repeated cross sectional surveys and ecological comparison of secular trends. BMJ 2013;346:f1515
36. Yki-Järvinen H. Type 2 diabetes: remission in just a week. Diabetologia 2011;54:2477-2479
37. Steven S, Lim EL, Taylor R. Population response to information on reversibility of type 2 diabetes. Diabet Med 2013;30:e135-e138
38. Peters C, Steven S, Taylor R. Reversal of type 2 diabetes by weight loss despite presence of macro- and micro-vascular complications. In Diabetes Case Studies: Real Problems, Practical Solutions. DrazninB, Ed. Alexandria, VA, American Diabetes Association, 2015, p. 271-274
39. Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012;308:2489-2496
40. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589
41. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, singlecentre, randomised controlled trial. Lancet 2015;386:964-973